US Patent Issued to AbbVie on July 22 for "Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-apyrrolo[2,3-e-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof" (American, German Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,689, issued on July 22, was assigned to AbbVie Inc. (North Chicago, Ill.).

"Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-apyrrolo[2,3-e-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof" was invented by Mohamed-Eslam F. Mohamed (Gurnee, Ill.), Ahmed A. Othman (Libertyville, Ill.), Aileen L. Pangan (La Grange, Ill.), Ben Klunder (Ludwigshafen, Germany), Heidi S. Camp (Winnetka, Ill.), Robert J. Padley (Highland Park, Ill.), Jeffrey W. Voss (Hudson, Mass.) and Cheng Thiam Tan (Grayslake, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to solid-state fo...